Bellien J

References (11)

Title : CRISPR\/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury - Leuillier_2023_J.Adv.Res_43_163
Author(s) : Leuillier M , Duflot T , Menoret S , Messaoudi H , Djerada Z , Groussard D , Denis RGP , Chevalier L , Karoui A , Panthu B , Thiebaut PA , Schmitz-Afonso I , Nobis S , Campart C , Henry T , Sautreuil C , Luquet SH , Beseme O , Feliu C , Peyret H , Nicol L , Henry JP , Renet S , Mulder P , Wan D , Tesson L , Heslan JM , Duche A , Jacques S , Ziegler F , Brunel V , Rautureau GJP , Monteil C , do Rego JL , do Rego JC , Afonso C , Hammock B , Madec AM , Pinet F , Richard V , Anegon I , Guignabert C , Morisseau C , Bellien J
Ref : J Adv Res , 43 :163 , 2023
Abstract :
PubMedSearch : Leuillier_2023_J.Adv.Res_43_163
PubMedID: 36585106
Gene_locus related to this paper: human-EPHX2

Title : Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats - Leuillier_2023_Cells_12_
Author(s) : Leuillier M , Platel V , Tu L , Feugray G , Thuillet R , Groussard D , Messaoudi H , Ottaviani M , Chelgham M , Nicol L , Mulder P , Humbert M , Richard V , Morisseau C , Brunel V , Duflot T , Guignabert C , Bellien J
Ref : Cells , 12 : , 2023
Abstract :
PubMedSearch : Leuillier_2023_Cells_12_
PubMedID: 36831332

Title : The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification - Varennes_2020_Int.J.Mol.Sci_21_
Author(s) : Varennes O , Mentaverri R , Duflot T , Kauffenstein G , Objois T , Lenglet G , Avondo C , Morisseau C , Brazier M , Kamel S , Six I , Bellien J
Ref : Int J Mol Sci , 21 : , 2020
Abstract :
PubMedSearch : Varennes_2020_Int.J.Mol.Sci_21_
PubMedID: 32560362

Title : Development of Improved Double Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in PBMCs of Diabetic and Pre-frontal Cortex of Multiple Sclerosis Patients - Li_2020_Anal.Chem_92_7334
Author(s) : Li D , Morisseau C , McReynolds CB , Duflot T , Bellien J , Nagra RM , Taha AY , Hammock BD
Ref : Analytical Chemistry , 92 :7334 , 2020
Abstract :
PubMedSearch : Li_2020_Anal.Chem_92_7334
PubMedID: 32253910

Title : Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome - Hamzaoui_2020_Front.Mol.Biosci_7_604042
Author(s) : Hamzaoui M , Roche C , Coquerel D , Duflot T , Brunel V , Mulder P , Richard V , Bellien J , Guerrot D
Ref : Front Mol Biosci , 7 :604042 , 2020
Abstract :
PubMedSearch : Hamzaoui_2020_Front.Mol.Biosci_7_604042
PubMedID: 33777999

Title : Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain - Kramer_2019_J.Med.Chem_62_8443
Author(s) : Kramer JS , Woltersdorf S , Duflot T , Hiesinger K , Lillich FF , Knoll F , Wittmann SK , Klingler FM , Brunst S , Chaikuad A , Morisseau C , Hammock BD , Buccellati C , Sala A , Rovati GE , Leuillier M , Fraineau S , Rondeaux J , Hernandez-Olmos V , Heering J , Merk D , Pogoryelov D , Steinhilber D , Knapp S , Bellien J , Proschak E
Ref : Journal of Medicinal Chemistry , 62 :8443 , 2019
Abstract :
PubMedSearch : Kramer_2019_J.Med.Chem_62_8443
PubMedID: 31436984

Title : Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients - Duflot_2019_Cardiovasc.Diabetol_18_35
Author(s) : Duflot T , Moreau-Grange L , Roche C , Iacob M , Wils J , Remy-Jouet I , Cailleux AF , Leuillier M , Renet S , Li D , Morisseau C , Lamoureux F , Richard V , Prevost G , Joannides R , Bellien J
Ref : Cardiovasc Diabetol , 18 :35 , 2019
Abstract :
PubMedSearch : Duflot_2019_Cardiovasc.Diabetol_18_35
PubMedID: 30885203

Title : Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction - Savina_2019_Diab.Vasc.Dis.Res__1479164119860215
Author(s) : Savina Y , Duflot T , Bounoure F , Kotzki S , Thiebaut PA , Serreau PA , Skiba M , Picquenot JM , Cornic M , Morisseau C , Hammock B , Imbert L , Cracowski JL , Richard V , Roustit M , Bellien J
Ref : Diab Vasc Dis Res , :1479164119860215 , 2019
Abstract :
PubMedSearch : Savina_2019_Diab.Vasc.Dis.Res__1479164119860215
PubMedID: 31267765

Title : Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice - Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
Author(s) : Roche C , Besnier M , Cassel R , Harouki N , Coquerel D , Guerrot D , Nicol L , Loizon E , Remy-Jouet I , Morisseau C , Mulder P , Ouvrard-Pascaud A , Madec AM , Richard V , Bellien J
Ref : American Journal of Physiology Heart Circ Physiol , 308 :H1020 , 2015
Abstract :
PubMedSearch : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
PubMedID: 25724490

Title : Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice - Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
Author(s) : Roche C , Guerrot D , Harouki N , Duflot T , Besnier M , Remy-Jouet I , Renet S , Dumesnil A , Lejeune A , Morisseau C , Richard V , Bellien J
Ref : Prostaglandins Other Lipid Mediat , 120 :148 , 2015
Abstract :
PubMedSearch : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
PubMedID: 26022136

Title : Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases - Duflot_2014_Expert.Opin.Drug.Discov_9_229
Author(s) : Duflot T , Roche C , Lamoureux F , Guerrot D , Bellien J
Ref : Expert Opin Drug Discov , 9 :229 , 2014
Abstract :
PubMedSearch : Duflot_2014_Expert.Opin.Drug.Discov_9_229
PubMedID: 24490654